JP2010538040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010538040A5 JP2010538040A5 JP2010523500A JP2010523500A JP2010538040A5 JP 2010538040 A5 JP2010538040 A5 JP 2010538040A5 JP 2010523500 A JP2010523500 A JP 2010523500A JP 2010523500 A JP2010523500 A JP 2010523500A JP 2010538040 A5 JP2010538040 A5 JP 2010538040A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- amino
- phenylsulfonyl
- phosphonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C1C2=*[C@](****3)C3CC*=*[C@]12 Chemical compound C1C2=*[C@](****3)C3CC*=*[C@]12 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007042154A DE102007042154A1 (de) | 2007-09-05 | 2007-09-05 | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| PCT/EP2008/061651 WO2009030715A1 (en) | 2007-09-05 | 2008-09-04 | Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010538040A JP2010538040A (ja) | 2010-12-09 |
| JP2010538040A5 true JP2010538040A5 (https=) | 2011-09-29 |
Family
ID=39967609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010523500A Pending JP2010538040A (ja) | 2007-09-05 | 2008-09-04 | アリールスルホニルアミノメチルホスホン酸誘導体、その製法及びその医薬組成物としての使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8163911B2 (https=) |
| EP (1) | EP2200987A1 (https=) |
| JP (1) | JP2010538040A (https=) |
| CA (1) | CA2698486A1 (https=) |
| DE (1) | DE102007042154A1 (https=) |
| WO (1) | WO2009030715A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007012284A1 (de) | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035334A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102008019838A1 (de) * | 2008-04-19 | 2009-12-10 | Boehringer Ingelheim International Gmbh | Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| US9326295B1 (en) | 2014-12-10 | 2016-04-26 | Sony Corporation | Method and apparatus for transmitting a-priori information in a communication system |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0604657T3 (da) | 1992-05-21 | 2000-04-17 | Otsuka Pharma Co Ltd | Phosphonsyrediesterderivat |
| TW260664B (https=) | 1993-02-15 | 1995-10-21 | Otsuka Pharma Factory Inc | |
| DE19753522A1 (de) | 1997-12-03 | 1999-06-10 | Boehringer Ingelheim Pharma | Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6312662B1 (en) | 1998-03-06 | 2001-11-06 | Metabasis Therapeutics, Inc. | Prodrugs phosphorus-containing compounds |
| JP2000247949A (ja) | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| GB9926302D0 (en) * | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| JP2003528106A (ja) * | 2000-03-22 | 2003-09-24 | メルク フロスト カナダ アンド カンパニー | Ｐｔｐ−１ｂ阻害薬としての硫黄置換アリールジフルオロメチルホスホン酸類 |
| GB0110797D0 (en) * | 2001-05-02 | 2001-06-27 | Celltech R&D Ltd | Chemical compounds |
| PE20021091A1 (es) | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| DE10215907A1 (de) | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| US7223796B2 (en) * | 2002-04-11 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| BR0312593A (pt) | 2002-07-11 | 2005-04-12 | Aventis Pharma Gmbh | Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação |
| US7262220B2 (en) * | 2002-07-11 | 2007-08-28 | Sanofi-Aventis Deutschland Gmbh | Urea- and urethane-substituted acylureas, process for their preparation and their use |
| RS20050019A (sr) * | 2002-07-12 | 2007-09-21 | Sanofi - Aventis Pharma Deutschland Gmbh., | Heterociklično supstituisani benzoilkarbamidi,postupak za njihovu proizvodnju i njihova primena kao leka |
| MXPA05012547A (es) | 2003-05-21 | 2006-05-25 | Prosidion Ltd | Inhibidores de amida de acido pirrolopiridina-2-carboxilico de fosforilasa de glucogeno. |
| ES2222832B1 (es) | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| ES2222827B1 (es) | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| ES2222829B1 (es) | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| EP1513085A1 (en) | 2003-09-08 | 2005-03-09 | Abb Research Ltd. | Method of scheduling maintenance actions |
| JP2005206492A (ja) | 2004-01-21 | 2005-08-04 | Sankyo Co Ltd | スルホンアミド化合物 |
| AU2005286717A1 (en) | 2004-09-21 | 2006-03-30 | Wyeth | Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| CN101094677A (zh) * | 2004-11-15 | 2007-12-26 | 塞普泰尔公司 | 蛋白酪氨酸磷酸酶抑制剂及其使用方法 |
| BRPI0617162B8 (pt) | 2005-10-07 | 2021-05-25 | Exelixis Inc | compostos inibidores de fosfatidilinositol 3-quinase composições farmacêuticas que os contem e métodos de uso dos mesmos |
| DE102007007751A1 (de) | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| WO2008103354A2 (en) | 2007-02-20 | 2008-08-28 | Cropsolution, Inc. | Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| DE102007012284A1 (de) * | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035334A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
-
2007
- 2007-09-05 DE DE102007042154A patent/DE102007042154A1/de not_active Withdrawn
-
2008
- 2008-09-04 US US12/676,319 patent/US8163911B2/en active Active
- 2008-09-04 EP EP08803622A patent/EP2200987A1/en not_active Withdrawn
- 2008-09-04 JP JP2010523500A patent/JP2010538040A/ja active Pending
- 2008-09-04 WO PCT/EP2008/061651 patent/WO2009030715A1/en not_active Ceased
- 2008-09-04 CA CA2698486A patent/CA2698486A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010538040A5 (https=) | ||
| AU2010224245B2 (en) | Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of Raf kinases | |
| EP3158867B1 (en) | A method for increasing the aqueous solubility of a bisphosphonic acid or a bisphosphonate | |
| AU2012279332B2 (en) | Compounds for the treatment of addiction | |
| ES2929906T3 (es) | Derivado de 2,3-dihidro-isoindol-1-ona como supresor de cinasa BTK, y composición farmacéutica que lo incluye | |
| JP6553629B2 (ja) | 線維芽細胞増殖因子受容体阻害剤としてのキノロン誘導体 | |
| SG175810A1 (en) | Pyrrolo [2, 3. b] pyridines which inhibit raf protein kinase | |
| CN105085483B (zh) | 激酶抑制剂及其应用 | |
| WO2010104973A1 (en) | Pyrrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases | |
| PH12014500092B1 (en) | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate | |
| CN1027507C (zh) | 新的磺酰化合物的制备方法 | |
| KR20130099064A (ko) | (아자)인돌리진 유도체 및 그 의약용도 | |
| TW201514180A (zh) | 一種ｊａｋ激酶抑制劑的硫酸氫鹽及其製備方法 | |
| CA2698486A1 (en) | Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions | |
| CN102497866B (zh) | 含有噁唑烷酮的二聚体化合物、组合物以及制备方法和用途 | |
| AU2020324561A1 (en) | Quinoline derivatives as protein kinase inhibitors | |
| CN102186824B (zh) | 稠环衍生物及其医药用途 | |
| JP2009539889A (ja) | スピロシクロピペラジン類の第四級アンモニウム塩化合物、その製造方法および使用 | |
| JP2013521289A (ja) | フルオロウラシル誘導体 | |
| CN103183709B (zh) | 一种米诺膦酸新晶型及其制备方法和用途 | |
| KR102046196B1 (ko) | 이미다조피리딘 유도체의 치료적 용도 | |
| JP3459407B2 (ja) | 安定剤としてグリシンを含む製薬学的製剤 | |
| Ibrahim et al. | Discovery and Development of Vemurafenib: First‐in‐Class Inhibitor of Mutant BRAF for the Treatment of Cancer | |
| CN105399719A (zh) | 一种伪麻黄碱类衍生物及其抗胃肠溃疡应用 | |
| CN105440016A (zh) | 吲哚、氮杂吲哚类衍生物、其制备方法及其在医药上的应用 |